Forward Pharma Reports First Quarter 2016 Financial And Operational Results

COPENHAGEN, Denmark, June 02, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the first quarter ended March 31, 2016. Net loss for the first quarter ended March 31, 2016 was $16.9 million, or $(0.36) per basic share versus net income of $6.0 million, or $0.13 per basic share for first quarter of 2015. On a non-GAAP basis, after removing the effect of non-cash income and expense items, our first quarter net loss for 2016 would have been $9.0 million, or $(0.19) per basic share. As of March 31, 2016, the Company had $170.8 million in cash, cash equivalents and marketable securities, with no debt outstanding.

Back to news